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A 50-year-old man was admitted to intensive care unit because 
of acute respiratory failure due interstitial pneumonia; after ad-
mission, a diagnosis of acute human immunodeficiency virus 
(HIV)-1 infection was made. Clinical and radiological improve-
ment was observed only after introduction of antiretroviral 
treatment. We discuss the hypothesis of interstitial pneumonia 
induced by the acute HIV-1 infection.
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CASE REPORT
A 50-year-old patient with unremarkable medical history 
was admitted to the emergency department (ED) with fever 
and acute respiratory failure. The patient had been febrile for 
5 days and developed rapidly worsening shortness of breath 
and dry cough in the last 24 hours. A chest x-ray performed 
in the ED showed bilateral multifocal involvement of the lungs 
with marked diffuse interstitial pattern and blood tests showed 
mildly elevated white blood cells (10 240/mm3 with normal dif-
ferential count) and increased C-reactive protein (CRP) (27 
mg/dL) with low procalcitonin (2 ng/mL). The patient denied 
recent travel history, close contacts with animals or contacts 
with sick people and intravenous drugs use; he reported cigar-
ette smoke and frequent unprotected heterosexual intercourse.
Physical examination revealed tachypnea (28 breaths/
minute), fever (101°F), hypotension (90/60 mmHg) and tachy-
cardia (110 bpm). Lungs showed diminished vesicular breath 
sounds. Physical examination was otherwise unremarkable.
The high risk for sexually transmitted infections and the 
clinical and radiological presentation raised the suspicion of 
Pneumocystis jirovecii pneumonia. Results from a human immu-
nodeficiency virus (HIV-1) antibody-antigen test (fourth-gen-
eration chemiluminescence assay; Roche Diagnostics) were 
positive. In addition, a weak positivity for pneumococcal 
urinary antigen (immune-chromatographic method) was 
detected. Arterial blood gas analysis showed severe hypoxemia 
(pH 7.46, pO2 50 mmHg, pCO2 27 mmHg, SatO2 84%) that 
could not be corrected by high oxygen supply with reservoir bag 
(pH 7.42, pO2 58 mmHg, pCO2 33 mmHg, SatO2 88%). After 
collection of blood cultures, empirical therapy with piperacil-
lin-tazobactam, levofloxacin, and cotrimoxazole was started. 
The patient was transferred to the intensive care unit and placed 
on mechanical ventilation.
On hospital day 4 the patient underwent bronchoscopy: 
Gram stain of bronchoalveolar lavage (BAL) was negative 
and no bacterial or fungal growth was observed on BAL cul-
tures, including aerobic bacteria, Legionella, molds, and yeasts. 
Bronchoalveolar lavage also tested negative for P jirovecii (im-
munofluorescence assay [IFA]), consequently, cotrimoxazole 
was ceased. No acid-fast bacteria were detected through Ziehl-
Neelsen staining and Mycobacterium tuberculosis-complex 
polymerase chain reaction (PCR) tested negative, as did cyto-
megalovirus, Epstein-Barr virus, herpes simplex virus 1/2, adeno-
virus, influenza A/B nucleic acid amplification, and Aspergillus 
galactomannan antigen. BAL cytology showed the following 
cellularity: macrophages (32%), neutrophils (63%), and lym-
phocytes (5%) and excluded the presence of neoplastic cells. On 
the same day, a pneumococcal urinary antigen test was repeated 
and the result was negative. Blood cultures performed before 
antibiotics as well as Legionella urinary antigen and serology 
for intracellular bacteria (Mycoplasma, Chlamydia, Legionella) 
were negative.
On hospital day 6 bronchoscopy was repeated. Again, Gram 
stain and Ziehl-Neelsen stain were negative and no bacterial 
or fungal growth was observed on BAL cultures. Pneumocystis 
jirovecii IFA and PCR-mediated tests for viruses were repeatedly 
negative. Procalcitonin was repeated twice and was found to be 
between 0.5 and 0.6 ng/mL.
No substantial clinical or radiological improvement was 
observed during the first week of antibiotic therapy. The patient 
was persistently febrile and in severe respiratory distress. 
Control chest x-rays persistently showed a marked interstitial 
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bilateral pattern with overlapping acute respiratory distress syn-
drome radiological signs (Figure 1A).
A confirmatory HIV Western blot (from blood collected on 
day 1) was negative. It was then repeated on day 5 and showed 
positivity only for gp41, confirming the diagnosis of acute 
HIV-1 infection (Fiebig stage IV). Plasma HIV-ribonucleic acid 
(RNA) was above 10 000 000 copies cps/mL, CD4+ T-cell count 
was 571 cells/mm3 (57%), whereas CD8+ T-cell count was 234 
cells/mm3 (23%), with CD4+/CD8+ ratio of 2.44 (Figure 1B). 
The patient reported a previous negative HIV test approxi-
mately 6 months before admission.
HIV-RNA on the last BAL was performed and quantified 
206 647 cps/mL. Antiretroviral treatment (ART) was intro-
duced on day 8 containing tenofovir disoproxil fumarate/
emtricitabine + darunavir/ritonavir 800/100 mg + raltegravir 
400 mg bid.
On the same day (day 8) the patient experienced worsening 
respiratory failure and onset of septic shock requiring noradren-
aline. Laboratory tests showed neutrophilia and increased CRP. 
Although the chest x-ray was unchanged, cultures of broncho-
aspirate (taken on day 8) were found to be positive for Klebsiella 
pneumoniae carbapenemase (KPC)-producing K. pneumoniae 
(KPC-Kp) (1 000 000 colony-forming units [cfu]/mL). Hence, 
on day 9 (when preliminary results of bronchoaspirate cultures 
became available) high-dose meropenem, gentamicin, and 
tygeclicine were started. Blood cultures taken on days 8 and 9 
gave negative results. Upon introduction of ART and the new 
antibacterial regimen, the patient became hemodynamically 
stable and showed progressive improvement of respiratory dis-
tress. Control chest x-rays showed radiological improvement on 
day 14, after 7 days of ART and 6 days of anti-KPC antibiotics.
On day 14 the patient was extubated and transferred to 
the pneumology ward and, on day 18, he was transferred to 
the infectious diseases unit. Here, oxygen supply was rapidly 
de-escalated as the patient experienced remarkable clinical 
improvement.
On day 27 follow-up bronchoscopy was performed: BAL 
cultures were still positive for KPC-Kp (100 000 cfu/mL), 
whereas HIV-RNA on BAL was diminished to 177 cps/mL. 
Antiretroviral treatment was well tolerated and on day 34, after 
complete clinical recovery, the patient was discharged. Plasma 
HIV-RNA after 8 and 12 weeks of ART decreased to 97 cps/mL 
and <40 cps/mL, respectively (Figure 1B).
DISCUSSION
We reported a case of acute HIV-1 infection presenting with 
bilateral multifocal interstitial pneumonia. A BAL tested nega-
tive for all pathogens possibly involved in the aetiology of the 
pneumonia.
The initial weak positivity of the pneumococcal urinary 
antigen was not confirmed at a second test performed a few days 
later, and it was not associated with the isolation of Streptococcus 
pneumoniae from either BAL or blood. This discrepancy lowers 
the likelihood of a pneumococcal aetiology, because several 
studies demonstrated that, in cases of proven pneumococcal 
pneumonia, the urinary antigen remains positive for several 
weeks and sometimes even months [1, 2]. Furthermore, the 
radiologic findings were unusual for a pneumococcal form, 
considering the marked interstitial pattern.
As we looked for alternative causative agents, the only posi-
tive result that was found on BAL was an elevated HIV-RNA 
(206.647 cps/mL), compatible with viral dissemination during 
acute HIV infection (AHI).
It is well known that HIV-1 impacts the pulmonary immune 
system through macrophage and lymphocyte activation, se-
cretion of proinflammatory cytokines and chemokines, and 
accumulation of CD8+ T cells [3]. Antiretroviral treatment, by 
controlling viral replication, is able to reduce the pulmonary 
inflammatory state [4, 5]. Evidence exists regarding the role of 
HIV-1 in causing pulmonary disease during chronic infection, 
with a much higher incidence of chronic respiratory diseases in 
HIV-infected patients compared with noninfected individuals, 
despite effective ART [6, 7]. Less is known about the role of HIV 
on the pulmonary system during AHI.
AHI can range from asymptomatic to a severe illness. 
Symptoms of AHI are described in 40%–90% of patients [8] and 
may reflect the immune response to the virus, particularly the 
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Figure 1. (A) Chest x-ray during the first days of intensive care unit stay (left) and 
1week after introduction of antiretroviral treatment ([ART] right). (B) Graph showing 
plasma and broncholavage (BAL) human immunodeficiency virus-ribonucleic acid 
(HIV-RNA) (cps/mL, on the left y axis) and CD4+ and CD8+ T-cell count (cells/mm3 
on the right y axis) over time (the horizontal axis represent days from admission). 
Open circles indicate values below the limit of detection. HIV Western blot results 
are shown below the graph.
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cytokine storm that follows infection, with resolution upon the 
partial control of viral replication [9] by the adaptive immune 
response, or by early initiation of antiretroviral therapy.
The most common symptoms of AHI are fever, rash, lym-
phadenopathy, pharyngitis, and, sometimes, aseptic meningi-
tis [9]. Respiratory involvement during AHI is rarely reported 
[10]. Occasionally, AHI can present with classic opportunis-
tic infections, and few cases of P jirovecii pneumonia during 
AHI are reported in the literature [11–13]. A recent study on 
the frequency and spectrum of unexpected clinical manifes-
tations during AHI reported respiratory tract involvement in 
5 of 290 patients with AHI (0.017%): in particular, 3 of 290 
patients (0.010 %) had viral pneumonia as the main clinical 
finding, and 2 of them were hospitalized due to severe respira-
tory distress. The remaining 3 of 5 patients with respiratory 
tract involvement presented with an upper respiratory tract 
infection [14].
Given the characteristics of the case report presented here, 
we wonder whether high HIV replication during AHI and the 
associated immune response could possibly be involved in the 
pathogenesis of the pneumonia. No clinical nor radiological 
improvement was observed during the first week of hospital-
ization, when only antibiotic therapy was administered to the 
patient.
The clinical deterioration on day 8 was associated with the 
isolation of KPC-Kp from BAL. We may consider the KPC as a 
nosocomial superinfection, and we speculate that the anti-KPC 
regimen led to the resolution of the septic shock, whereas ART 
therapy contributed to the progressive resolution of the pre-ex-
isting interstitial pneumonia.
CONCLUSIONS
Our hypothesis of an HIV-induced pneumonia represents 
a clinical diagnosis of exclusion. Additional analyses could 
support this hypothesis such as the characterization of HIV 
tropism, genetic compartmentalization analysis in the lung 
versus plasma, HIV-specific CD8+ T cells on BAL and plasma 
as well as the study of proinflammatory cytokines on BAL [15].
Unfortunately, we could not perform any additional 
immunological or molecular investigation on our patient’s 
BAL and we can only speculate about the role of HIV in the 
pathogenesis of this unusual case of pneumonia during acute 
infection. However, this clinical observation may encourage 
clinicians to perform HIV testing and also look for acute infec-
tion, especially in cases of lower respiratory tract infection with 
no alternative explaination.
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